Study: Detection of specific proteins in the blood may reveal the risk of dementia
-
Last Update: 2015-07-08
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
The risk of Alzheimer's disease and mild cognitive impairment in the future can be estimated by measuring the level of specific proteins in the blood, a new Japanese study has found The team believes that this will help to detect such diseases as early as possible and take interventions Alzheimer's disease is believed to be related to the excessive accumulation of β - amyloid protein in the brain At the beginning of 20 years before the onset of the disease, β - amyloid protein will gradually accumulate in the brain β - amyloid protein can cause damage to nerve cells and affect the function of synapses which are responsible for memory and cognition Human beings have the mechanism of keeping β - amyloid from accumulating in healthy state Researchers from the University of Tsukuba in Japan found that complement protein, apolipoprotein and thyroxin play an important role in the process of excreting β - amyloid protein and curbing its toxicity After analyzing the data of cognitive disease survey, the research team found that the content of these three proteins in the blood of the elderly with mild cognitive impairment and dementia was gradually reduced compared with the elderly without disease The team's experiment confirmed that taking a few milliliters of blood to test the content of these three proteins can determine the cognitive health level of the tested person and the future risk of disease with an accuracy of about 80%.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.